바로가기 메뉴
본문 바로가기
주메뉴 바로가기
순예은

Ye Eun Sun

Neurology

Specialty

Treatment hours

Mon, Tue, Wed, Thur, Fri, Sat
Mon Tue Wed Thu Fri Sat
Education


Career


Main Activities


Research/Publication

1. Sun Y, Na HK, Yoon SH, Vo QP, Park CW, Lee JH, Choi YY, Yoo HS, Sohn YH, Lyoo CH, Lee PH. Olfactory Dysfunction as a Window Into the Heterogeneity of Parkinson Disease. Eur J Neurol. 2025 Nov;32(11):e70404. doi: 10.1111/ene.70404. PMID: 41186960; PMCID: PMC12584115.


2. Sun Y, Na HK, Jeon S, Ye BS, Lee PH, Yoo HS, Lyoo CH. Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study. Neurology. 2026 Feb 10;106(3):e214573. doi: 10.1212/WNL.0000000000214573. Epub 2026 Jan 9. PMID: 41512212.


3. Park CJ, Sun Y, Jeong HJ, Na HK, Yoon SH, Lee SK, Lyoo CH, Sohn YH, Jeong SH, Lee PH. Association of choroid plexus volume with brain atrophy and glucose metabolism in multiple system atrophy. Sci Rep. 2026 Jan 16. doi: 10.1038/s41598-026-35850-6. Epub ahead of print. PMID: 41545586.


4. Park CW, Choi Y, Sun Y, Lee HS, Lee PH, Kim YJ, Sohn YH, Lee J, Chung SJ. Visuospatial dysfunction indicates an increased risk of rapid dementia conversion in Parkinson's disease. Alzheimers Dement. 2026 Jan;22(1):e71130. doi: 10.1002/alz.71130. PMID: 41540811; PMCID: PMC12808930.


5. Kim S, Na HK, Sun Y, Yoon YJ, Chung SJ, Sohn YH, Lyoo CH, Lee PH. Regional Burden of Enlarged Perivascular Spaces and Cognition and Neuropsychiatric Symptoms in Drug-Naive Patients With Parkinson Disease. Neurology. 2024 Jun 25;102(12):e209483. doi: 10.1212/WNL.0000000000209483. Epub 2024 Jun 4. PMID: 38833653.